Hemispherx: U.S. Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate in Ebola Virus Rodent Study
February 02, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today the results of a new efficacy study of Ampligen® in a...
USAMRIID Reports Genetic Changes in Ebola Virus May Impede Potential Treatments
January 26, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that in a new publication in the journal mBio, scientists at...
U.S. Unprepared for Ebola, According to Journal of American Physicians and Surgeons
December 15, 2014 10:20 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 15, 2014 (GLOBE NEWSWIRE) -- Despite spending billions on biological defense and pandemic preparedness, the U.S. is woefully unprepared, as recent experience with Ebola...
Hemispherx Announces Data Showing Inhibition of Ebola by Ampligen(R) Enlarged by Howard University Research
December 09, 2014 09:51 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Dec. 9, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that it has received a new research report (dated December 5,...
Helmsley Charitable Trust Announces $2.2 Million in Emergency Funding for Ebola Response Efforts
November 18, 2014 09:33 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, Nov. 18, 2014 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced a $2.2 million grant to GlobalGiving to support both local and international...
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
November 18, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the...
CONNECTICUT CHILDREN'S TO HOST EBOLA WEBINAR NOVEMBER 19
November 17, 2014 16:58 ET
|
Connecticut Childrens Medical Center
HARTFORD, Conn., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Ebola seems to be all anyone is talking about these days and with the most recent case now confirmed in New York City, many are scrambling with...
Ampligen(R) Blocks Critical Ebola Viral Disease (EVD) Protein Which is Linked to High Mortality in Man
November 17, 2014 09:08 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that it had received a new research report from Professor...
UBA Commits $1million to the Ebola Fight
November 13, 2014 07:30 ET
|
The Tony Elumelu Foundation
Lagos, Nigeria, Nov. 13, 2014 (GLOBE NEWSWIRE) -- The United Bank for Africa (UBA) Board Chairman, Tony O Elumelu,
has announced the donation of $1million, to assist the fight
against Ebola, currently...
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014
November 10, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...